PTGS2 and colorectal carcinoma: To solve these inconsistencies, Wang et al. conducted a meta-analysis involving 5 studies (1854 cases and 2950 controls) and concluded COX-2 rs689466 polymorphism was not associated with CRC susceptibility [35].